86 related articles for article (PubMed ID: 1314578)
1. Expression of MBP-HCV NS1/E2 fusion protein in E. coli and detection of anti-NS1/E2 antibody in type C chronic liver disease.
Mita E; Hayashi N; Ueda K; Kasahara A; Fusamoto H; Takamizawa A; Matsubara K; Okayama H; Kamada T
Biochem Biophys Res Commun; 1992 Mar; 183(3):925-30. PubMed ID: 1314578
[TBL] [Abstract][Full Text] [Related]
2. Expression of HCV E2/NS1 protein as a fusion protein with maltose binding protein: detection of anti-E2/NS1 antibody in chronic liver disease.
Yokosuka O; Omata M; Ito Y; Ohto M
Gut; 1993; 34(2 Suppl):S64-5. PubMed ID: 7686121
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus core protein: synthesis, affinity purification and immunoreactivity with infected human sera.
Khanna A; Ray R
Gene; 1995 Feb; 153(2):185-9. PubMed ID: 7533115
[TBL] [Abstract][Full Text] [Related]
4. Expression of hepatitis C virus core protein as a fusion protein with maltose binding protein. Detection of anti-hepatitis C core antibody by western blot.
Yokosuka O; Ito Y; Sakuma J; Imazeki F; Ohto M; Omata M
Dig Dis Sci; 1993 Apr; 38(4):626-30. PubMed ID: 7681745
[TBL] [Abstract][Full Text] [Related]
5. Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain.
Hayhurst A
Protein Expr Purif; 2000 Feb; 18(1):1-10. PubMed ID: 10648163
[TBL] [Abstract][Full Text] [Related]
6. Expression and purification of E2/NS1 protein of hepatitis C virus and detection of anti-E2/NS1 antibodies in chronic liver disease patients.
Pandya J; Chakraborti A; Chawla Y
J Biomed Sci; 2003; 10(2):276-82. PubMed ID: 12595764
[TBL] [Abstract][Full Text] [Related]
7. Solubility of proteins isolated from inclusion bodies is enhanced by fusion to maltose-binding protein or thioredoxin.
Sachdev D; Chirgwin JM
Protein Expr Purif; 1998 Feb; 12(1):122-32. PubMed ID: 9473466
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic characterization of purified NS3 serine proteinase of hepatitis C virus expressed in Escherichia coli.
Mori A; Yamada K; Kimura J; Koide T; Yuasa S; Yamada E; Miyamura T
FEBS Lett; 1996 Jan; 378(1):37-42. PubMed ID: 8549798
[TBL] [Abstract][Full Text] [Related]
9. Expression of a hepatitis C virus NS3 protease-NS4A fusion protein in Escherichia coli.
Inoue H; Sakashita H; Shimizu Y; Yamaji K; Yokota T; Sudo K; Shigeta S; Shimotohno K
Biochem Biophys Res Commun; 1998 Apr; 245(2):478-82. PubMed ID: 9571178
[TBL] [Abstract][Full Text] [Related]
10. Membrane protein topology determination by proteolysis of maltose binding protein fusions.
Miller KW; Konen PL; Olson J; Ratanavanich KM
Anal Biochem; 1993 Nov; 215(1):118-28. PubMed ID: 8297003
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of antibody to hepatitis C virus envelope 2 glycoprotein in patients with chronic hepatitis C virus infection.
Yuki N; Hayashi N; Kasahara A; Hagiwara H; Mita E; Ohkawa K; Katayama K; Fusamoto H; Kamada T
Hepatology; 1996 May; 23(5):947-52. PubMed ID: 8621173
[TBL] [Abstract][Full Text] [Related]
12. High efficiency prokaryotic expression and purification of a portion of the hepatitis C core protein and analysis of the immune response to recombinant protein in BALB/c mice.
Hitomi Y; McDonnell WM; Baker JR; Askari FK
Viral Immunol; 1995; 8(2):109-19. PubMed ID: 8825296
[TBL] [Abstract][Full Text] [Related]
13. Processing of hepatitis C viral polyprotein in Escherichia coli.
Komoda Y; Hijikata M; Tanji Y; Hirowatari Y; Mizushima H; Kimura K; Shimotohno K
Gene; 1994 Aug; 145(2):221-6. PubMed ID: 8056335
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures and solution conformations of a dominant-negative mutant of Escherichia coli maltose-binding protein.
Shilton BH; Shuman HA; Mowbray SL
J Mol Biol; 1996 Nov; 264(2):364-76. PubMed ID: 8951382
[TBL] [Abstract][Full Text] [Related]
15. Antibody responses to hepatitis C envelope proteins in patients with acute or chronic hepatitis C.
Fournillier-Jacob A; Lunel F; Cahour A; Cresta P; Frangeul L; Perrin M; Girard M; Wychowski C
J Med Virol; 1996 Oct; 50(2):159-67. PubMed ID: 8915882
[TBL] [Abstract][Full Text] [Related]
16. Production of the chimeric-binding protein, maltose-binding protein-protein A, by gene fusion.
Kobatake E; Ikariyama Y; Aizawa M
J Biotechnol; 1995 Jan; 38(3):263-8. PubMed ID: 7765875
[TBL] [Abstract][Full Text] [Related]
17. Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies.
Bach H; Mazor Y; Shaky S; Shoham-Lev A; Berdichevsky Y; Gutnick DL; Benhar I
J Mol Biol; 2001 Sep; 312(1):79-93. PubMed ID: 11545587
[TBL] [Abstract][Full Text] [Related]
18. Detection of antibody to hepatitis C E2/NS1 protein in patients with type C hepatitis.
Yokosuka O; Ito Y; Imazeki F; Ohto M; Omata M
Biochem Biophys Res Commun; 1992 Nov; 189(1):565-71. PubMed ID: 1280430
[TBL] [Abstract][Full Text] [Related]
19. Export of maltose-binding protein species with altered charge distribution surrounding the signal peptide hydrophobic core in Escherichia coli cells harboring prl suppressor mutations.
Puziss JW; Strobel SM; Bassford PJ
J Bacteriol; 1992 Jan; 174(1):92-101. PubMed ID: 1729228
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of bacterio-opsin in Escherichia coli as a water-soluble fusion to maltose binding protein: efficient regeneration of the fusion protein and selective cleavage with trypsin.
Chen GQ; Gouaux JE
Protein Sci; 1996 Mar; 5(3):456-67. PubMed ID: 8868482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
